// App-Quantinova.ai

e12577 : Composite scoring combining OncotypeDX risk with circulating tumor cell status improves prognostication.

Researchers

Presenter

  • Nadeem Bilani

Principal Investigators

  • Leah Elson

  • Elizabeth Blessing Elimimian

  • Hong Liang

  • Zeina A. Nahleh

Medical Centers

  • Cleveland Clinic Florida, Weston, FL

  • Cleveland Clinic Florida, Weston, FL

  • Cleveland Clinic Florida, El Paso, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved